The Global Fertility Testing Devices Market is valued at US$ 544.3 Million in 2022 and is expected to reach US$ 967.8 Million by 2029 with a CAGR of 8.57% over the forecast period.
Global Fertility Testing Devices Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2023-2029- Increasing awareness and acceptance of fertility testing among individuals worldwide are some of the major factors driving the growth of Global Fertility Testing Devices Market.
Fertility testing devices are medical devices designed to assist in testing and determining fertility in both men and women. These devices can help individuals and couples in planning pregnancies and can also aid in the diagnosis of infertility issues. There are various types of fertility testing devices available in the market, such as ovulation prediction kits, fertility monitors, male fertility testing kits, and pregnancy testing kits. These devices use different technologies such as urine-based, saliva-based, blood-based, and basal body temperature-based. The history of fertility testing devices dates to the 1920s, when the first fertility tests were developed to detect ovulation in women. These early tests used methods such as measuring changes in cervical mucus and basal body temperature.
The Covid-19 pandemic has had a mixed impact on the fertility testing devices market. On one hand, the pandemic has led to a decrease in fertility treatments as many clinics and hospitals have had to suspend or limit their services. This has resulted in a temporary decrease in demand for fertility testing devices. On the other hand, the pandemic has led to a rise in demand for at-home fertility testing devices. As people have been forced to stay at home due to lockdowns and social distancing measures, there has been an increased interest in self-monitoring of health, including fertility. At-home fertility testing devices, such as ovulation predictor kits, have seen a surge in demand as people seek to manage their fertility at home.
Global fertility testing devices market is segmented based on product, purchase type, application, end-user, distribution channel and region & country level. Based on Product, the fertility testing devices market is segmented into ovulation prediction kit, fertility monitor, male fertility testing kits and pregnancy testing kits. Based on purchase type, the fertility testing devices market is segmented into over the counter and prescription based. Based on application, the fertility testing devices market is segmented into female fertility testing device and male fertility testing device. Based on end-user, the fertility testing device market is segmented into home care settings, hospitals, fertility clinics and others. Based on distribution channel, the fertility testing devices market is segmented into online and offline.
The regions covered in this fertility testing devices market are North America, Europe, Asia-Pacific, Latin, and the Middle East. Based on a country level, the market of Fertility Testing Devices is subdivided into the U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, Southeast Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Some of the key players for Fertility Testing Devices are -
Growing infertility issues is one of the major factors driving the growth of fertility testing devices market. Infertility affects both men and women and can be caused by various factors, including age, lifestyle choices, medical conditions, and genetic factors. For instance; according to WHO; near about 48 million couples & 186 million individuals facing infertility problem globally. As a result, there is a growing need for diagnostic tools that can accurately detect and diagnose infertility issues in both men and women. These devices include ovulation prediction kits, fertility monitors, male fertility testing kits, and pregnancy testing kits, among others. These devices help couples to identify the fertile window and increase their chances of conceiving a child. Therefore, increasing awareness about infertility issues and the availability of advanced fertility testing devices have contributed to the growth of the fertility testing devices market.
Moreover, increasing first time pregnancy age fueling the market growth of fertility testing devices. Delaying pregnancy can result in reduced fertility due to factors such as age-related decline in ovarian function, increased risk of chromosomal abnormalities in eggs, and increased prevalence of medical conditions such as endometriosis and polycystic ovary syndrome. Fertility testing devices can help women track their menstrual cycles, monitor hormone levels, and identify the fertile window for conception. The average age of first-time mothers has been steadily increasing in many countries, including the United States, Canada, and several European countries. For instance; in the United States, the average age of first-time mothers was 26.3 years. Similarly, in Canada, the average age of first-time mothers was 28.5 years in 2019, up from 24.9 years in 1980. As women delay their first pregnancy, there is a growing need for fertility testing devices to help them understand their fertility status and plan for parenthood accordingly.
However, high cost and limited accuracy, alternative options may hamper the growth of fertility testing devices market. In spite of that, increasing technological advancements in this field may create more opportunities for the further growth of the market.
Geographically, North America accounts for the leading share in the fertility testing devices market. The North American fertility testing devices is driven by increasing technological advancements, increasing awareness, large costumer base, strong distribution network. One of the reasons for North America's dominance in the fertility testing market is the high prevalence of infertility in the region.
For instance; according to the Centers for Disease Control and Prevention (CDC), about 10% of women in the United States, or 6.1 million, have difficulty getting pregnant or staying pregnant. This has led to increased demand for fertility testing devices, as couples try to determine the cause of their infertility and seek appropriate treatments.
Europe is the second dominating region for the fertility testing devices market, driven by factors such as the increasing trend of delaying first-time pregnancies and the availability of advanced healthcare facilities. Also, Europe has a well-established healthcare infrastructure with advanced medical technologies, including fertility testing devices. This makes it easier for women to access these devices and receive accurate diagnoses and treatments for infertility.
For example; Germany is one of the largest markets for fertility testing devices in Europe due to its advanced healthcare facilities. Furthermore, infertility is becoming increasingly common in Europe, with around 10-15% of couples experiencing fertility problems. This has led to a growing demand for fertility testing devices, as more women seek to understand their fertility status and plan their pregnancies accordingly.
Singapore’s BUZUD Announced Launch Of LH Ovulation Rapid Test Kits For Self-Testing
On December 12th, 2022; Singapore’s based manufacturer of medical devices and appliances BUZUD, announces launch of LH Ovulation Rapid Test for Self-Testing, designed and produced in 3 configurations: midstream, cassette type and strip type. LH Ovulation Rapid Test is a rapid, one step test for the qualitative detection of Luteinizing Hormone (LH) in urine, to help you in detection of ovulation.
Proov Got FDA Nod for its at-Home Ovulation Testing Kit
On March 11th, 2020; Proov got FDA nod for its at-home ovulation testing kit. The test was developed to help women find out if they are ovulating on a regular basis. Users can send away for the kit and get test strips, which can determine the presence of progesterone metabolite PdG in urine, which is linked to a woman's ovulation cycle.
|Historical data||2016 - 2021|
|Forecast Period||2022 - 2029|
|Market Size in 2022:||USD 514.1 Million|
|Base year considered||2021|
|Forecast Period CAGR %:||
|Market Size Expected in 2028:||USD 852.9 Million|
|Tables, Charts & Figures:||175|
|Companies||Andrology Solutions, AVA Science Inc., Biozhena Corporation, Church & Dwight Co., Inc., Clearblue, Cyclotest GmbH, Fairhaven Health, LLC, Fertility Focus Limited, Geratherm Medical AG, Hilin Life Products, Inc., Mira, Prestige Consumer Healthcare Inc., Sensiia, SPD Swiss Precision Diagnostics GmbH, TTK Healthcare Ltd, Others|
|Segments Covered||By Product, By Purchase Type, By Application, By End-User, By Distribution Channel|
|Regional Analysis||North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa|
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us email@example.comJOIN US
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
© Copyright 2023-24 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®